Validity of Medical Record Abstraction and Electronic Health Record-Generated Reports to Assess Performance on Cardiovascular Quality Measures in Primary Care.
Aspirin
/ therapeutic use
Blood Pressure Determination
/ statistics & numerical data
Cardiovascular Diseases
/ diagnosis
Cross-Sectional Studies
Electronic Health Records
/ standards
Female
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors
/ therapeutic use
Primary Health Care
/ methods
Quality Improvement
Quality Indicators, Health Care
Reference Standards
Reproducibility of Results
Risk Assessment
/ methods
Smoking
/ epidemiology
United States
/ epidemiology
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
01 07 2020
01 07 2020
Historique:
entrez:
29
7
2020
pubmed:
29
7
2020
medline:
29
12
2020
Statut:
epublish
Résumé
Cardiovascular disease is the leading cause of death in the United States. To improve cardiovascular outcomes, primary care must have valid methods of assessing performance on cardiovascular clinical quality measures, including aspirin use (aspirin measure), blood pressure control (BP measure), and smoking cessation counseling and intervention (smoking measure). To compare observed performance scores measured using 2 imperfect reference standard data sources (medical record abstraction [MRA] and electronic health record [EHR]-generated reports) with misclassification-adjusted performance scores obtained using bayesian latent class analysis. This cross-sectional study used a subset of the 2016 aspirin, BP, and smoking performance data from the Healthy Hearts for Oklahoma Project. Each clinical quality measure was calculated for a subset of a practice's patient population who can benefit from recommended care (ie, the eligible population). A random sample of 380 eligible patients were included for the aspirin measure; 126, for the BP measure; and 115, for the smoking measure. Data were collected from 21 primary care practices belonging to a single large health care system from January 1 to December 31, 2018, and analyzed from February 21 to April 17, 2019. The main outcomes include performance scores for the aspirin, BP, and smoking measures using imperfect MRA and EHRs and estimated through bayesian latent class models. A total of 621 eligible patients were included in the analysis. Based on MRA and EHR data, observed aspirin performance scores were 76.0% (95% bayesian credible interval [BCI], 71.5%-80.1%) and 74.9% (95% BCI, 70.4%-79.1%), respectively; observed BP performance scores, 80.6% (95% BCI, 73.2%-86.9%) and 75.1% (95% BCI, 67.2%-82.1%), respectively; and observed smoking performance scores, 85.7% (95% BCI, 78.6%-91.2%) and 75.4% (95% BCI, 67.0%-82.6%), respectively. Misclassification-adjusted estimates were 74.9% (95% BCI, 70.5%-79.1%) for the aspirin performance score, 75.0% (95% BCI, 66.6%-82.5%) for the BP performance score, and 83.0% (95% BCI, 74.4%-89.8%) for the smoking performance score. Ensuring valid performance measurement is critical for value-based payment models and quality improvement activities in primary care. This study found that extracting information for the same individuals using different data sources generated different performance score estimates. Further research is required to identify the sources of these differences.
Identifiants
pubmed: 32721028
pii: 2768724
doi: 10.1001/jamanetworkopen.2020.9411
pmc: PMC7388024
doi:
Substances chimiques
Platelet Aggregation Inhibitors
0
Aspirin
R16CO5Y76E
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e209411Subventions
Organisme : NIGMS NIH HHS
ID : U54 GM104938
Pays : United States
Références
Med Care. 2005 Mar;43(3):266-75
pubmed: 15725983
BMC Health Serv Res. 2018 Jun 4;18(1):404
pubmed: 29866120
Am J Epidemiol. 1995 Feb 1;141(3):263-72
pubmed: 7840100
PLoS One. 2019 Oct 11;14(10):e0223832
pubmed: 31603953
N Engl J Med. 2011 Sep 29;365(13):e27
pubmed: 21913835
Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):589-91
pubmed: 22811503
MMWR Morb Mortal Wkly Rep. 2011 Sep 16;60(36):1248-51
pubmed: 21918495
Am J Epidemiol. 2014 Feb 15;179(4):423-31
pubmed: 24272278
Biometrics. 2004 Jun;60(2):388-97
pubmed: 15180664
J Clin Epidemiol. 1988;41(9):923-37
pubmed: 3054000
Clin Infect Dis. 2012 Aug;55(3):322-31
pubmed: 22523263
Prev Vet Med. 2017 Mar 1;138:37-47
pubmed: 28237234
Circulation. 2015 Jan 27;131(4):e29-322
pubmed: 25520374